source
- Satellos Bioscience presents early adult data for Duchenne muscular dystrophy pill ahead of child trialSatellos Bioscience, a Canadian biotech, has released early results from its Phase 2 study of an oral therapy for Duchenne muscular dystrophy in adult patients. The data are intended to strengthen…
- HHS pushes FDA to formalize public release of rejection letters to drug makersHHS announced it is preparing a new FDA regulation that would codify the agency's practice of publishing complete response letters (CRLs) that inform pharmaceutical companies of a drug's rejection.…